{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:09:42Z","timestamp":1785434982399,"version":"3.56.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.sleep.2023.05.001","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T17:54:27Z","timestamp":1683827667000},"page":"229-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Safety and pharmacodynamics of a single infusion of danavorexton in adults with obstructive sleep apnea experiencing excessive daytime sleepiness despite adequate use of CPAP"],"prefix":"10.1016","volume":"107","author":[{"given":"Richard K.","family":"Bogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Maynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Neuwirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Faessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Swick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2023.05.001_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1513\/pats.200707-114MG","article-title":"Pathophysiology of adult obstructive sleep apnea","volume":"5","author":"Eckert","year":"2008","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.sleep.2023.05.001_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/diseases9040088","article-title":"Association and risk factors for obstructive sleep apnea and cardiovascular diseases: a systematic review","volume":"9","author":"Mitra","year":"2021","journal-title":"Diseases"},{"key":"10.1016\/j.sleep.2023.05.001_bib3","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJM199304293281704","article-title":"The occurrence of sleep-disordered breathing among middle-aged adults","volume":"328","author":"Young","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sleep.2023.05.001_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1440-1843.2011.02082.x","article-title":"Obesity and craniofacial structure as risk factors for obstructive sleep apnoea: impact of ethnicity","volume":"17","author":"Sutherland","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.sleep.2023.05.001_bib5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1513\/AnnalsATS.202006-696FR","article-title":"Excessive daytime sleepiness in obstructive sleep apnea. Mechanisms and clinical management","volume":"18","author":"Lal","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.sleep.2023.05.001_bib6","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/thx.2003.015867","article-title":"Sleep. 4: sleepiness, cognitive function, and quality of life in obstructive sleep apnoea\/hypopnoea syndrome","volume":"59","author":"Engleman","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.sleep.2023.05.001_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archinte.163.5.565","article-title":"Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis","volume":"163","author":"Patel","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sleep.2023.05.001_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jsr.12039","article-title":"Scientific Council of the Sleep Registry of the French Federation of Pneumology-FFP. Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure","volume":"22","author":"Gasa","year":"2013","journal-title":"J\u00a0Sleep Res"},{"key":"10.1016\/j.sleep.2023.05.001_bib9","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1183\/09031936.00016808","article-title":"Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study","volume":"33","author":"P\u00e9pin","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.sleep.2023.05.001_bib10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/sleep\/30.6.711","article-title":"Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning","volume":"30","author":"Weaver","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.05.001_bib11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1183\/09031936.00124708","article-title":"Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients","volume":"34","author":"Koutsourelakis","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.sleep.2023.05.001_bib12","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1016\/j.chest.2021.06.084","volume":"160","author":"Patil","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.sleep.2023.05.001_bib13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/sleep\/27.2.194","article-title":"Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions","volume":"27","author":"Veasey","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.05.001_bib14","doi-asserted-by":"crossref","first-page":"10060","DOI":"10.1523\/JNEUROSCI.0857-07.2007","article-title":"Selective loss of catecholaminergic wake active neurons in a murine sleep apnea model","volume":"27","author":"Zhu","year":"2007","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.sleep.2023.05.001_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5665\/sleep.3306","article-title":"Effects of chronic sleep fragmentation on wake-active neurons and the hypercapnic arousal response","volume":"37","author":"Li","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.05.001_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fneur.2015.00109","article-title":"Degeneration in arousal neurons in chronic sleep disruption modeling sleep apnea","volume":"6","author":"Zhu","year":"2015","journal-title":"Front Neurol"},{"key":"10.1016\/j.sleep.2023.05.001_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41583-018-0097-x","article-title":"The neurobiological basis of narcolepsy","volume":"20","author":"Mahoney","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.sleep.2023.05.001_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/j.2040-4603.2020.tb00118.x","article-title":"Orexin in respiratory and autonomic regulation, health and diseases","volume":"10","author":"Barnett","year":"2020","journal-title":"Compr Physiol"},{"key":"10.1016\/j.sleep.2023.05.001_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.autneu.2019.01.007","article-title":"Control of the cardiovascular and respiratory systems during sleep","volume":"218","author":"Benarroch","year":"2019","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.sleep.2023.05.001_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.sleep.2023.05.001_bib21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.sleep.2023.05.001_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainres.2018.04.002","article-title":"A\u00a0comparison of the orexin receptor distribution in the brain between diurnal Nile grass rats (Arvicanthis niloticus) and nocturnal mice (Mus musculus)","volume":"1690","author":"Ikeno","year":"2018","journal-title":"Brain Res"},{"key":"10.1016\/j.sleep.2023.05.001_bib23","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1038\/s41598-022-12601-x","article-title":"Orexin 2 receptor (OX2R) protein distribution measured by autoradiography using radiolabeled OX2R-selective antagonist EMPA in rodent brain and peripheral tissues","volume":"12","author":"Mitsukawa","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.sleep.2023.05.001_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-pharmtox-010510-100528","article-title":"Orexin receptors: pharmacology and therapeutic opportunities","volume":"51","author":"Scammell","year":"2011","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.sleep.2023.05.001_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172794","article-title":"TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice","volume":"187","author":"Yukitake","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.sleep.2023.05.001_bib26","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207531119","article-title":"Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients","volume":"119","author":"Evans","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.sleep.2023.05.001_bib27","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1212\/WNL.96.15_supplement.4278","article-title":"Safety and efficacy of TAK-925 in adults with obstructive sleep apnea who experience excessive daytime sleepiness despite adequate use of CPAP","volume":"96","author":"Rubens","year":"2021","journal-title":"Neurology"},{"issue":"Suppl.\u00a02681","key":"10.1016\/j.sleep.2023.05.001_bib28","article-title":"Safety and pharmacodynamics of a single infusion of TAK-925 in adults with idiopathic hypersomnia","volume":"98","author":"Mignot","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2023.05.001_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13878","article-title":"Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates andhealthy individuals","author":"Evans","year":"2023","journal-title":"J\u00a0Sleep Res"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.sleep.2023.05.001_bib30","article-title":"Selective orexin 2 receptor agonist TAK-925 to treat narcolepsy: results of a randomized, double-blind, placebo-controlled, multiple-ascending dose, phase 1 study in patients with narcolepsy type 2","volume":"29","author":"Tanaka","year":"2020","journal-title":"J\u00a0Sleep Res"},{"key":"10.1016\/j.sleep.2023.05.001_bib31","article-title":"Excessive daytime sleepiness independently predicts increased cardiovascular risk after myocardial infarction","volume":"7","author":"Xie","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.sleep.2023.05.001_bib32","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1161\/STROKEAHA.108.530824","article-title":"Excessive daytime sleepiness is an independent risk indicator for cardiovascular mortality in community-dwelling elderly: the three city study","volume":"40","author":"Empana","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.sleep.2023.05.001_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1532-5415.2000.tb03901.x","article-title":"The Cardiovascular Health Study Research Group. Daytime sleepiness predicts mortality and cardiovascular disease in older adults","volume":"48","author":"Newman","year":"2000","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.sleep.2023.05.001_bib34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/sleep\/28.4.464","article-title":"Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea\/hypopnea syndrome","volume":"28","author":"Black","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.05.001_bib35","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.clinthera.2006.05.013","article-title":"Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea\/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults","volume":"28","author":"Roth","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.sleep.2023.05.001_bib36","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5664\/jcsm.2912","article-title":"Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated Japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study","volume":"9","author":"Inoue","year":"2013","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.sleep.2023.05.001_bib37","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.chest.2018.11.005","article-title":"Tones 4 study investigators. Solriamfetol for the treatment of excessive sleepiness in OSA: a placebo-controlled randomized withdrawal study","volume":"155","author":"Strollo","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.sleep.2023.05.001_bib38","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.peptides.2009.07.025","article-title":"Involvement of orexin-A on micturition reflex in normal and cyclophosphamide-induced cystitis bladder in rat","volume":"30","author":"Kobayashi","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.sleep.2023.05.001_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/NSS.S53721","article-title":"Obstructive sleep apnea and psychomotor vigilance task performance","volume":"6","author":"Batool-Anwar","year":"2014","journal-title":"Nat Sci Sleep"},{"key":"10.1016\/j.sleep.2023.05.001_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/sleep\/26.2.117","article-title":"The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation","volume":"26","author":"Van Dongen","year":"2003","journal-title":"Sleep"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945723001703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945723001703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:43:42Z","timestamp":1761407022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945723001703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":40,"alternative-id":["S1389945723001703"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2023.05.001","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and pharmacodynamics of a single infusion of danavorexton in adults with obstructive sleep apnea experiencing excessive daytime sleepiness despite adequate use of CPAP","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Takeda Pharmaceuticals. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}